• New facilities adjacent to the Cambridge Science Park will comprise CL2 wet labs, dry labs and office space over six storeys • Latest ground-up development in Cambridge delivered by Kadans Science Partner to provide the facilities needed by health, life science and technology companies

• Trial aims to deliver clinical proof-of-concept and assess the safety profile of novel long acting ENaC inhibitor ETD001 • ETD001, a CFTR mutation agnostic approach to CF, is focussed on providing a novel treatment for members of the CF community that do not benefit from currently available mutation-targeted therapies

We are proud media partners of Elrig's Drug Discovery 2024!

Gaelic Laboratories unveils its new website today, launching an upgraded and expanded laboratory technology base for advanced analytical testing, and a newly re-fitted Beta-Lactam manufacturing facility, using the latest state-of-the art technology.

Come and join us for the 13th edition of BioFIT, on December 3rd & 4th, 2024 in Lille and digital meetings days on December 11th & 12th, 2024!

Synexa Life Sciences, a global provider of biomarker and bioanalytical solutions to the pharmaceutical, biotech, and CRO industries, proudly announces its enrollment in the My Green Lab Certification Program. This strategic move underscores Synexa’s commitment to ensuring its laboratories remain at the forefront of environmental sustainability.

LSX Nordic Congress gathers the founders and CEOs of innovative start-ups through to publicly listed healthcare giants, and everyone in between. It represents the breadth and depth of cutting-edge research and technology driving the advances in the industry right now and in the near future.

For life sciences and biotech companies, access to affordable dedicated lab spaces is hard to come by. Labs are prohibitively expensive to build and operate, posing significant financial barriers to innovation and research.

Energy and cost-efficient processing and packaging solutions.

ACHEMA 2024 took place 10-14 June 2024 in Frankfurt, Germany, with 2,842 exhibitors from 56 nations covering the latest equipment and innovative processes for the chemical, pharmaceutical and food processing industries

Site Profile & Oversight Tool (SPOT) and Intelligent Medical Coding (IMC) unveiled by RBQM innovator at DIA Global Annual Meeting 2024

EQT is pleased to announce that the EQT Healthcare Growth Strategy and the EQT Growth Fund have agreed to acquire a majority stake in CluePoints (the “Company”), with meaningful reinvestment from the management team and existing shareholders Summit Partners and Clinimetrics SA, which was also a co-founder of the Company.